Benzinga·2026-01-27 01:18Market Overview - Major U.S. benchmarks finished higher, with the Dow Jones Industrial Average climbing 0.6% to 49,412.40, the S&P 500 adding 0.5% to 6,950.23, and the Nasdaq advancing 0.4% to 23,601.35, driven by anticipation surrounding the earnings of the "Magnificent Seven" stocks, including Microsoft and Meta Platforms [1] USA Rare Earth Inc. - USA Rare Earth shares surged 7.87% to close at $26.72, reaching an intraday high of $32.07 and a low of $25.80, with a 52-week range of $5.56 to $43.98 [2] - The stock's rise follows news of a $1.6 billion investment from the Trump administration, acquiring a 10% stake, which includes 16.1 million shares and warrants for an additional 17.6 million shares at $17.17 each [3] GameStop Corp - GameStop's stock climbed 4.46% to close at $24.01, with a high of $25.01 and a low of $22.95, and a 52-week range of $19.93 to $35.81 [4] - The rally was fueled by investor Michael Burry's disclosure of a fresh stake in the company, adding momentum to a rally driven by CEO Ryan Cohen's insider purchases [4] CoreWeave - CoreWeave shares rose 5.73% to $98.31, hitting an intraday high of $108.65 and a low of $98.05, with a 52-week range of $33.52 to $187 [5] - The increase follows Nvidia Corporation's $2 billion investment in the company, aimed at accelerating AI adoption globally [5] Zoom Communications Inc. - Zoom's stock jumped 11.28% to $95.46, with an intraday high of $95.83 and a low of $86.40, and a 52-week range of $64.41 to $95.83 [6] - The surge is attributed to renewed investor interest in Zoom's early investment in AI startup Anthropic, which analysts believe could be worth $2 billion to $4 billion [6] UnitedHealth Group Incorporated - UnitedHealth's stock fell 1.29% to $351.64, with a high of $354.79 and a low of $347.27, and a 52-week range of $234.6 to $606.36 [7] - The stock fell sharply by 8.6% to $321.30 in extended trading after reports of proposed flat Medicare Advantage rates for 2027, with payments rising just 0.09% [8] - Analysts have revised forecasts ahead of the company's earnings release, with CEO Stephen Hemsley addressing lawmakers about rising healthcare costs [8]